Images
RNE has interviewed Antonio Zorzano, head of the Complex Metabolic Diseases and Mitochondria lab at IRB Barcelona, about his research on DOR protein deficiency. Depletion of this protein stimulates the generation of new adipose cells and leads to a less toxic form of obesity. In the interview, Zorzano says that this study will allow the identification of therapeutic targets, which in turn will allow the development of new drugs. This will be a step forward as only three approved drugs are available through a medical prescription in Spain and they are not totally effective.
Link to RNE
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
